Pharmacogenomics Corner

Back to articles

New guideline updates simvastatin dosing recommendations based on gene polymorphism


When SLCO1B1 genotyping is available in the clinical environment, information on the presence of a variant that increases simvastatin levels and muscle toxicity risk (rs4149056) should be used to individualize simvastatin doses and initiate routine creatinine kinase (CK) monitoring, according to a recent guideline.